U.S. Markets close in 2 hrs 4 mins

Intercept Pharmaceuticals, Inc. (ICPT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
21.03-1.11 (-5.01%)
As of 1:55PM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.58
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 395.98
52 Week Low 318.15
50-Day Moving Average 323.89
200-Day Moving Average 331.19

Share Statistics

Avg Vol (3 month) 31.1M
Avg Vol (10 day) 3845.42k
Shares Outstanding 533.02M
Implied Shares Outstanding 6N/A
Float 28.14M
% Held by Insiders 116.26%
% Held by Institutions 182.50%
Shares Short (Mar 14, 2021) 47.24M
Short Ratio (Mar 14, 2021) 45.92
Short % of Float (Mar 14, 2021) 434.76%
Short % of Shares Outstanding (Mar 14, 2021) 421.94%
Shares Short (prior month Feb 11, 2021) 46.03M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020


Profit Margin -87.91%
Operating Margin (ttm)-69.27%

Management Effectiveness

Return on Assets (ttm)-20.28%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)312.69M
Revenue Per Share (ttm)9.48
Quarterly Revenue Growth (yoy)16.50%
Gross Profit (ttm)307.37M
EBITDA -213.49M
Net Income Avi to Common (ttm)-274.88M
Diluted EPS (ttm)-8.34
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)469.67M
Total Cash Per Share (mrq)14.23
Total Debt (mrq)575.51M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.05
Book Value Per Share (mrq)-5.05

Cash Flow Statement

Operating Cash Flow (ttm)-170.03M
Levered Free Cash Flow (ttm)-61.79M